Table 2.
Psychological burden | NF1 | PSC | PAH | MFS | Total N |
Aspects related to specific diagnoses | |||||
Rumination | 3 | 3 | |||
Avolition | 2 | 2 | |||
Suicidal thoughts | 2 | 2 | |||
Using disease as excuse for other problems | 2 | 2 | |||
Shared aspects named by two diagnostic groups | |||||
Worries/anxiety | 8 | 3 | 11 | ||
Shame | 3 | 2 | 5 | ||
Problems with the patient role | 1 | 3 | 4 | ||
Loss of control | 1 | 1 | 2 | ||
Shared aspects named by three diagnostic groups | |||||
Self-doubts, feelings of insufficiency | 1 | 1 | 5 | 7 | |
Cognitive impairments | 3 | 1 | 2 | 6 | |
Diagnosis perceived as life-changing experience | 1 | 2 | 2 | 5 | |
Loss of quality of life | 1 | 1 | 1 | 3 | |
Shared aspects named by all four diagnostic groups | |||||
Depressive mood | 1 | 2 | 1 | 8 | 12 |
Numbers represent the total number of mentions and are displayed for each diagnosis individually as well as across all diagnostic groups; grey cells represent categories, which were mentioned at least once in a diagnostic group.
MFS, Marfan syndrome; NF1, neurofibromatosis type 1; PAH, pulmonary arterial hypertension; PSC, primary sclerosing cholangitis.